diabetes mellitus, type-2 patient information
Jump to navigation
Jump to search
Notes
- annual out-of-pocket costs for guideline recommended drugs to treat patients with diabetes mellitus type 2 & established cardiovascular disease, heart failure, or chronic kidney disease (flozins, glutides) under Medicare part D range from $1,200 to $2,500 (2020)[9]
Additional terms
References
- ↑ Am I at Risk for Type 2 Diabetes? http://diabetes.niddk.nih.gov/dm/pubs/riskfortype2/index.htm
- ↑ Diabetes: NIH Senior Health http://nihseniorhealth.gov/diabetes/toc.html
- ↑ Harvard Health: Type 2 Diabetes Mellitus https://www.health.harvard.edu/a_to_z/type-2-diabetes-mellitus-a-to-z
- ↑ Mayo clinic: Type 2 diabetes https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/symptoms-causes/syc-20351193
- ↑ American Diabetes Association: Type 2 Diabetes. Life doesn't end with type 2 diabetes. https://www.diabetes.org/diabetes/type-2
- ↑ Centers for Disease Control & Prevention (CDC) Type 2 Diabetes https://www.cdc.gov/diabetes/basics/type2.html
- ↑ MedlinePlus: Diabetes Type 2 https://medlineplus.gov/diabetestype2.html
- ↑ Clevelaned clinic: Diabetes Mellitus: An Overview https://my.clevelandclinic.org/health/diseases/7104-diabetes-mellitus-an-overview
- ↑ 9.0 9.1 DeJong C et al. Out-of-pocket costs for novel guideline-directed diabetes therapies under Medicare Part D. JAMA Intern Med 2020 Sep 14; [e-pub] PMID: https://www.ncbi.nlm.nih.gov/pubmed/32926091 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2770721